Healio and Cardiology Today have aggregated a list of the top headlines of 2022 in heart failure and transplantation.
Readers were most interested in the xenotransplantation of genetically modified pig hearts into human recipients; the first partial heart transplant in a newborn with truncus arteriosus; an FDA panel declining to back the approval of omecamtiv mecarbil; and more.
A team at NYU Langone Health successfully transplanted two genetically engineered pig hearts into recently deceased humans in June and July, part of an effort to create a xenotransplantation protocol for people with